{"name":"Yan Jin","slug":"yan-jin","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5wODhnYklWZ0lQcVNzY1pDMU5GNzR2Q21qSmpNM1hrc1RyODdVMndLUklZSVlFWThVUi0ybVVCb01mWGx1M29CSzNHYy1PT0IyNlc2SnpXSUhkRjlEa1RF?oc=5","date":"2025-12-24","type":"trial","source":"Nature","summary":"Urine-based HIV-1 self-testing in China: A cross-sectional diagnostic accuracy and usability study - Nature","headline":"Urine-based HIV-1 self-testing in China: A cross-sectional diagnostic accuracy and usability study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE5obDZFU2lYUldWRE14cXE0RGJHcGdsdFlfOHozY29zU3RjNW12cmV1Sld6ZVJhcVdVQkQ5UXUxR3NfOUF5ZTROQ3FVR2ZVM2NyalFKZGQ5VEhfenIwc0FNMUdxV2hUd1hGcFExenFzaw?oc=5","date":"2025-03-05","type":"pipeline","source":"Wiley Online Library","summary":"Photo- and Cerium-Mediated C─C Bond Cleavage for the Deconstructive Diversification of Cyclic Acids - Wiley Online Library","headline":"Photo- and Cerium-Mediated C─C Bond Cleavage for the Deconstructive Diversification of Cyclic Acids","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5kbUhiRmdQb2JXX0N5aDduTFNrN2pjd2RETGxwZzFQX0owbTdWTkUtVng2dEZBU05TOXZOQXdnT0NJUkpoNHdwcVFnekxMRi00d2hZdUl4c3VtOVMyUjg0?oc=5","date":"2024-01-18","type":"pipeline","source":"Nature","summary":"A modular chemoenzymatic cascade strategy for the structure-customized assembly of ganglioside analogs - Nature","headline":"A modular chemoenzymatic cascade strategy for the structure-customized assembly of ganglioside analogs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE5GY1dTVHFxQ2RqcVBIRVhkcHV4ZVRKVE03bHU5TDVvb3FiZDhjaVpWajR5anhPTXZoblRVX3BjeFU3NW9xYlVON3FJT3E0aHN6ZWVodlU3WjR0RXlrajJiVGdtZw?oc=5","date":"2023-10-02","type":"pipeline","source":"ACS Publications","summary":"Electrostatic-Mediated Binding of DNA to Lysozymes: Evaluation of Aptamer-Based Assays for Highly Positively Charged Targets - ACS Publications","headline":"Electrostatic-Mediated Binding of DNA to Lysozymes: Evaluation of Aptamer-Based Assays for Highly Positively Charged Tar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPcnRZb2dteUFCNzZVUm8yczhHTXhYNi03b1hDYmRzdjh5UDRnS1cyeHF0UkVaMDlWd1RTZF96X2xJMkIwTXhRZFB3eG5UV19CUW1fRlBTTURoc0NZNmJENWpYdkw3MDE5ZjZ5cmxQZjZqR2JfOTJLTDRIVnFBM0RjWUxlT3lFV0g3WUxrSURxVG9UcDNsMkNtNEMxNkZNa3p2N29zRHZ2RzlZcWxiWFNn?oc=5","date":"2021-07-07","type":"pipeline","source":"ArentFox Schiff","summary":"Schiff Counsels Altaris on its $1.55B Acquisition of Padagis - ArentFox Schiff","headline":"Schiff Counsels Altaris on its $1.55B Acquisition of Padagis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE0za2NHUXNkX1g4WHdEQ2NpRzR1aDZHUHFXR3hsbGVGNC05X2pxU2ZKZE45U253LWliZU9qQkFHWV83eUV3bldwYTJHT25UQ1BLS2RMbUI1ck9KM1ZpSFRV?oc=5","date":"2017-09-25","type":"regulatory","source":"Nature","summary":"Network Analysis of Drug–target Interactions: A Study on FDA-approved New Molecular Entities Between 2000 to 2015 - Nature","headline":"Network Analysis of Drug–target Interactions: A Study on FDA-approved New Molecular Entities Between 2000 to 2015","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}